Skip to main content

New Products

  • PreMama launches powdered prenatal multi

    PROVIDENCE, R.I. — PreMama last week announced the launch of a Target-exclusive: PreMama Complete, a prenatal vitamin formulated for women who are pregnant, breast feeding or trying to conceive.

  • CorePharma launches generic Ritalin

    MIDDLESEX, N.J. — CorePharma on Thursday announced the launch of methylphenidate hydrochloride tablets USP, the generic version of Ritalin from Novartis. Methylphenidate is intended for the treatment of narcolepsy and attention deficit disorders.

    The drug is available in 5-,10- and 20-mg strengths. Methylphenidate immediate release tablets had U.S. sales of approximately $243 million as of December 2013, according to IMS Data.

     

  • Ajanta Pharma launches risperidone tablets

    BRIDGEWATER, N.J. — Ajanta Pharma USA on Friday announced the launch of risperidone tablets (0.25-mg, 0.5-mg, 1-mg, 2-mg, 3-mg and 4-mg), the generic version of Risperdal. The drug is used to treat schizophrenia and bipolar disorder.

    Sales of branded and generic risperidone totalled approximately $147 million for the 12 months ending March 2014, according to IMS Health.

  • Enaltus announces three additions to its ScarAway line

    SUWANEE, Ga. — Enaltus recently announced three new additions to its line of ScarAway scar removal products. 

    First is ScarAway Scar Repair Gel, featuring patented Kelo-cote technology, a transparent, self-drying 100%-silicone gel designed to improve the appearance of scars and prevent abnormal and excessive scar formation. The transparent gel offers convenient application for custom scar prevention and treatment that can begin the moment a wound has healed or sutures are removed. ScarAway Scar Repair Gel retails for a suggested $29.99. 

  • FDA approves sensor, mobile app designed to better control asthma, COPD

    MADISON, Wis. — Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, earlier this week announced that the Food and Drug Administration granted 510(k) clearance to market its latest generation of the Propeller platform, including a new sensor.

  • FDA approves Zontivity tabs

    SILVER SPRING, Md. — The Food and Drug Administration on Thursday approved Zontivity (vorapaxar) tablets, an anti-platelet agent that's designed to decrease the tendency of platelets to clump together to form a blood clot. Zontivity is the first in a new class of drugs called a protease-activated receptor-1 (PAR-1) antagonist, the agency said.

  • Telehealth provider Teladoc to accelerate growth with AmeriDoc acquisition

    DALLAS — Teladoc, a telehealth provider with more than 7.5 million members, has announced the acquisition of AmeriDoc, a telehealth company founded in 2007.

    Teladoc stated that the acquisition supports its strategy for growth into new and fast-growing market segments.

  • Wegmans makes Lifeclinic 500 health stations available to patients for better health tracking

    ROCHESTER, N.Y. — Wegmans Food Markets is making it easy for patients to monitor their blood pressure with a stop to the pharmacy at any store, the company announced Wednesday. That’s where customers can find a health station that lets them take their own vital statistics and track them over time, providing the kind of record doctors often ask patients to keep. The Lifeclinic 500 stations can measure blood pressure, pulse, weight and calculate body mass index.

X
This ad will auto-close in 10 seconds